323 related articles for article (PubMed ID: 28044214)
1. Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.
Kakugawa Y; Tada H; Kawai M; Suzuki T; Nishino Y; Kanemura S; Ishida T; Ohuchi N; Minami Y
Breast Cancer Res Treat; 2017 Feb; 162(1):115-125. PubMed ID: 28044214
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol.
Honma N; Saji S; Hirose M; Horiguchi S; Kuroi K; Hayashi S; Utsumi T; Harada N
Cancer Sci; 2011 Oct; 102(10):1848-54. PubMed ID: 21707867
[TBL] [Abstract][Full Text] [Related]
3. Relation of BMI and physical activity to sex hormones in postmenopausal women.
McTiernan A; Wu L; Chen C; Chlebowski R; Mossavar-Rahmani Y; Modugno F; Perri MG; Stanczyk FZ; Van Horn L; Wang CY;
Obesity (Silver Spring); 2006 Sep; 14(9):1662-77. PubMed ID: 17030978
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
[TBL] [Abstract][Full Text] [Related]
6. Serum sex hormone levels after menopause and subsequent breast cancer.
Berrino F; Muti P; Micheli A; Bolelli G; Krogh V; Sciajno R; Pisani P; Panico S; Secreto G
J Natl Cancer Inst; 1996 Mar; 88(5):291-6. PubMed ID: 8614008
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
8. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
9. Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer.
Kakugawa Y; Minami Y; Tateno H; Inoue H; Fujiya T
Breast Cancer; 2007; 14(3):269-76. PubMed ID: 17690503
[TBL] [Abstract][Full Text] [Related]
10. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
[TBL] [Abstract][Full Text] [Related]
11. Adiposity and sex hormones in postmenopausal breast cancer survivors.
McTiernan A; Rajan KB; Tworoger SS; Irwin M; Bernstein L; Baumgartner R; Gilliland F; Stanczyk FZ; Yasui Y; Ballard-Barbash R
J Clin Oncol; 2003 May; 21(10):1961-6. PubMed ID: 12743149
[TBL] [Abstract][Full Text] [Related]
12. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
[TBL] [Abstract][Full Text] [Related]
13. Serum sex hormones and breast cancer risk factors in postmenopausal women.
Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ
Cancer Causes Control; 2001 Jan; 12(1):47-59. PubMed ID: 11227925
[TBL] [Abstract][Full Text] [Related]
15. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
Baglietto L; Severi G; English DR; Krishnan K; Hopper JL; McLean C; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):492-502. PubMed ID: 20086116
[TBL] [Abstract][Full Text] [Related]
16. [Determination of intratumoral estrone (E1) and estradiol (E2) in primary breast cancer tissues by sensitive HPLC-RIA].
Nagaya N; Toi M; Sunahara S; Kurimoto F; Tominaga T
Gan To Kagaku Ryoho; 1997 Feb; 24(3):329-36. PubMed ID: 9051136
[TBL] [Abstract][Full Text] [Related]
17. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
18. The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.
Tworoger SS; Rosner BA; Willett WC; Hankinson SE
Breast Cancer Res; 2011 Oct; 13(5):R99. PubMed ID: 22017816
[TBL] [Abstract][Full Text] [Related]
19. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
20. Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.
Secreto G; Meneghini E; Venturelli E; Cogliati P; Agresti R; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
Int J Biol Markers; 2011; 26(4):241-6. PubMed ID: 22180173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
